<!--
Homepage version latest-updates

Instruction:

1. Always use three hashtags (###) to start a section title.

2. Please include an anchor link to the detailed latest updates page in each section title.
   You can click the üîó symbol on detailed latest updates page to find out the corresponding anchor link.
   Please follow the existing sections for the correct format.

3. One paragraph description for each section. The paragraph should contain less than ~200 chars.

4. Dated updates should be listed in descending order.

5. For links from covdb.stanford.edu, please remove the leading "https://covdb.stanford.edu".
   For example, "https://covdb.stanford.edu/page/updates/" should be shorten to "/page/updates/".

6. Try not to include plain links such as [https://stanford.cloud-cme.com/default.aspx?P=0&EID=38044](https://stanford.cloud-cme.com/default.aspx?P=0&EID=38044).
   Please include readable content in the bracket, e.g. [video](https://stanford.cloud-cme.com/default.aspx?P=0&EID=38044).

7. Please do not delete this instruction.

-->
### Database Entries (Jul 19)
Dougan M, Nirula A, et int., and Skovronsky DM. [‚ÄúBamlanivimab plus Etesevimab in Mild or Moderate Covid-19.‚Äù](/search/?article=Dougan21) _New England Journal of Medicine_, 2021. [doi.org/10.1056/nejmoa2102685](https://doi.org/10.1056/nejmoa2102685). \[[PubMed34260849](https://www.ncbi.nlm.nih.gov/pubmed/34260849/)\]
### Database Entries (Jul 19)
Fischer W, Eron JJ, et int., and Painter WP. [‚ÄúMolnupiravir, an Oral Antiviral Treatment for COVID-19.‚Äù](/search/?article=Fischer21) _medRxiv_, 2021. [doi.org/10.1101/2021.06.17.21258639](https://doi.org/10.1101/2021.06.17.21258639). \[[PubMed34159342](https://www.ncbi.nlm.nih.gov/pubmed/34159342/)\] \[[PMC8219109](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219109/)\]
### Database Entries (Jul 19)
Frazier L, Lubinski B, et int., and Whittaker G. [‚ÄúSpike protein cleavage-activation mediated by the SARS-CoV-2 P681R mutation: a case-study from its first appearance in variant of interest (VOI) A.23.1 identified in Uganda.‚Äù](/search-drdb/?article=Frazier21) _bioRxiv : the preprint server for biology_, 2021. [doi.org/10.1101/2021.06.30.450632](https://doi.org/10.1101/2021.06.30.450632). \[[PubMed34230931](https://www.ncbi.nlm.nih.gov/pubmed/34230931/)\] \[[PMC8259907](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259907/)\]

### Database Entries (Jul 19)
Lustig Y, Zuckerman N, et int., and Mandelboim M. [‚ÄúNeutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel.‚Äù](/search-drdb/?article=Lustig21) _Eurosurveillance_, 2021. [doi.org/10.2807/1560-7917.es.2021.26.26.2100557](https://doi.org/10.2807/1560-7917.es.2021.26.26.2100557). \[[PubMed34212838](https://www.ncbi.nlm.nih.gov/pubmed/34212838/)\]
### Database Entries (Jul 19)
Ryu D, Kang B, et int., and Lee S. [‚ÄúTherapeutic efficacy of CT-P59 against P.1 variant of SARS-CoV-2.‚Äù](/search-drdb/?article=Ryu21b) _bioRxiv_, 2021. [doi.org/10.1101/2021.07.08.451696](https://doi.org/10.1101/2021.07.08.451696).
### Database Entries (Jul 19)
Sapkal GN, Yadav PD, et int., and Bhargava B. [‚ÄúNeutralization Of Delta Variant With Sera Of Covishield Vaccinees And Covid-19 Recovered Vaccinated Individuals.‚Äù](/search-drdb/?article=Sapkal21c) __, 2021. [doi.org/10.1101/2021.07.01.450676](https://doi.org/10.1101/2021.07.01.450676).
### Database Entries (Jul 19)
Tada T0, Zhou H, et int., and Landau NR. [‚ÄúSars-Cov-2 Lambda Variant Remains Susceptible To Neutralization By Mrna Vaccine-Elicited Antibodies And Convalescent Serum.‚Äù](/search-drdb/?article=Tada21d) __, 2021. [doi.org/10.1101/2021.07.02.450959](https://doi.org/10.1101/2021.07.02.450959).
### Database Entries (Jul 19)
Weinreich DM, Sivapalasingam S, et int., and Yancopoulos GD. [‚ÄúREGEN-COV Antibody Cocktail Clinical Outcomes Study in Covid-19 Outpatients.‚Äù](/search/?article=Weinreich21b) _medRxiv_, 2021. [doi.org/10.1101/2021.05.19.21257469](https://doi.org/10.1101/2021.05.19.21257469).
### Database Entries (Jul 09)
Acevedo ML, Alonso-Palomares L, et int., and Soto-Rifo R. [‚ÄúInfectivity and immune escape of the new SARS-CoV-2 variant of interest Lambda.‚Äù](/search-drdb/?article=Acevedo21) _medRxiv_, 2021. [doi.org/10.1101/2021.06.28.21259673](https://doi.org/10.1101/2021.06.28.21259673).
### Database Entries (Jul 09)
Alter G, Yu J, et int., and Barouch DH. [‚ÄúImmunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans.‚Äù](/search-drdb/?article=Alter21) _Nature_, 2021. [doi.org/10.1038/s41586-021-03681-2](https://doi.org/10.1038/s41586-021-03681-2). \[[PubMed34107529](https://www.ncbi.nlm.nih.gov/pubmed/34107529/)\]
### Database Entries (Jul 09)
Choi A, Koch M, et int., and Edwards DK. [‚ÄúSerum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants.‚Äù](/search-drdb/?article=Choi21) _bioRxiv_, 2021. [doi.org/10.1101/2021.06.28.449914](https://doi.org/10.1101/2021.06.28.449914).
### Database Entries (Jul 09)
Cohen MS, Nirula A, et int., and Taffet G. [‚ÄúEffect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities.‚Äù](/search/?article=Cohen21) _JAMA_, 2021. [doi.org/10.1001/jama.2021.8828](https://doi.org/10.1001/jama.2021.8828). \[[PubMed34081073](https://www.ncbi.nlm.nih.gov/pubmed/34081073/)\] \[[PMC8176388](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176388/)\]
### Database Entries (Jul 09)
Imai M, Halfmann PJ, et int., and Kawaoka Y. [‚ÄúCharacterization of a new SARS-CoV-2 variant that emerged in Brazil.‚Äù](/search-drdb/?article=Imai21) _Proceedings of the National Academy of Sciences_, 2021. [doi.org/10.1073/pnas.2106535118](https://doi.org/10.1073/pnas.2106535118). \[[PubMed34140350](https://www.ncbi.nlm.nih.gov/pubmed/34140350/)\]
### Database Entries (Jul 09)
Jongeneelen M, Kaszas K, et int., and Brandenburg B. [‚ÄúAd26.COV2.S elicited neutralizing activity against Delta and other SARS-CoV-2 variants of concern.‚Äù](/search-drdb/?article=Jongeneelen21) _bioRxiv_, 2021. [doi.org/10.1101/2021.07.01.450707](https://doi.org/10.1101/2021.07.01.450707).
### Database Entries (Jul 09)
Monin L, Laing AG, et int., and Irshad S. [‚ÄúSafety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.‚Äù](/search-drdb/?article=Monin21) _The Lancet Oncology_, 2021. [doi.org/10.1016/S1470-2045(21)00213-8](https://doi.org/10.1016/S1470-2045(21)00213-8). \[[PubMed33930323](https://www.ncbi.nlm.nih.gov/pubmed/33930323/)\] \[[PMC8078907](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078907/)\]
### Database Entries (Jul 09)
O‚ÄôBrien MP, Forleo-Neto E, et int., and Weinreich DM. [‚ÄúSubcutaneous REGEN-COV Antibody Combination for Covid-19 Prevention.‚Äù](/search/?article=Obrien21b) _medRxiv_, 2021. [doi.org/10.1101/2021.06.14.21258567](https://doi.org/10.1101/2021.06.14.21258567). \[[PubMed34159344](https://www.ncbi.nlm.nih.gov/pubmed/34159344/)\] \[[PMC8219114](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219114/)\]
### Database Entries (Jul 09)
Ryu D, Song R, et int., and Lee S. [‚ÄúTherapeutic effect of CT-P59 against SARS-CoV-2 South African variant.‚Äù](/search-drdb/?article=Ryu21) _Biochemical and Biophysical Research Communications_, 2021. [doi.org/10.1016/j.bbrc.2021.06.016](https://doi.org/10.1016/j.bbrc.2021.06.016). \[[PubMed34119826](https://www.ncbi.nlm.nih.gov/pubmed/34119826/)\] \[[PMC8180667](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180667/)\]
### Database Entries (Jul 09)
Turner JS, O‚ÄôHalloran JA, et int., and Ellebedy AH. [‚ÄúSARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.‚Äù](/search-drdb/?article=Turner21) _Nature_, 2021. [doi.org/10.1038/s41586-021-03738-2](https://doi.org/10.1038/s41586-021-03738-2). \[[PubMed34182569](https://www.ncbi.nlm.nih.gov/pubmed/34182569/)\]
### Database Entries (Jul 09)
Wall EC, Wu M, et int., and Bauer DL. [‚ÄúAZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.‚Äù](/search-drdb/?article=Wall21b) _The Lancet_, 2021. [doi.org/10.1016/S0140-6736(21)01462-8](https://doi.org/10.1016/S0140-6736(21)01462-8). \[[PubMed34197809](https://www.ncbi.nlm.nih.gov/pubmed/34197809/)\] \[[PMC8238446](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238446/)\]
### Database Entries (Jul 09)
Weinreich DM, Sivapalasingam S, et int., and Yancopoulos GD. [‚ÄúREGEN-COV Antibody Cocktail in Outpatients with Covid-19.‚Äù](/search/?article=Weinreich21) _medRxiv_, 2021. [doi.org/10.1101/2021.06.09.21257915](https://doi.org/10.1101/2021.06.09.21257915).
### Database Entries (Jun 28)
Mlcochova P, Kemp S, et int., and Agrawal A. [‚ÄúSARS-CoV-2 B.1.617.2 Delta variant emergence and vaccine breakthrough.‚Äù](/search-drdb/?article=Mlcochova21) _Research Square_, 2021. [doi.org/10.21203/rs.3.rs-637724/v1](https://doi.org/10.21203/rs.3.rs-637724/v1).
### Database Entries (Jun 28)
Wall EC, Wu M, et int., and Bauer DL. [‚ÄúNeutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination.‚Äù](/search-drdb/?article=Wall21) _The Lancet_, 2021. [doi.org/10.1016/s0140-6736(21)01290-3](https://doi.org/10.1016/s0140-6736(21)01290-3). \[[PubMed34090624](https://www.ncbi.nlm.nih.gov/pubmed/34090624/)\] \[[PMC8175044](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175044/)\]
### Database Entries (Jun 22)
Horby PW, Mafham M, et int., and Landray MJ. [‚ÄúCasirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.‚Äù](/search/?article=Horby21) _medRxiv_, 2021. [doi.org/10.1101/2021.06.15.21258542](https://doi.org/10.1101/2021.06.15.21258542).
### Database Entries (Jun 22)
Liu C, Ginn HM, et int., and Screaton GR. [‚ÄúReduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.‚Äù](/search-drdb/?article=Liu21f) _Cell_, 2021. [doi.org/10.1016/j.cell.2021.06.020](https://doi.org/10.1016/j.cell.2021.06.020).
### Database Entries (Jun 22)
O‚ÄôBrien MP, Forleo-Neto E, et int., and Weinreich DM. [‚ÄúSubcutaneous REGEN-COV Antibody Combination in Early SARS-CoV-2 Infection.‚Äù](/search/?article=Obrien21) _medRxiv_, 2021. [doi.org/10.1101/2021.06.14.21258569](https://doi.org/10.1101/2021.06.14.21258569).
### Database Entries (Jun 22)
Walser M, Rothenberger S, et int., and Amstutz P. [‚ÄúHighly potent anti-SARS-CoV-2 multi-DARPin therapeutic candidates.‚Äù](/search/?article=Walser20) _bioRxiv_, 2020. [doi.org/10.1101/2020.08.25.256339](https://doi.org/10.1101/2020.08.25.256339).
### Database Entries (Jun 22)
Zou J, Xie X, et int., and Shi P. [‚ÄúThe effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization.‚Äù](/search-drdb/?article=Zou21) _npj Vaccines_, 2021. [doi.org/10.1038/s41541-021-00313-8](https://doi.org/10.1038/s41541-021-00313-8). \[[PubMed33767200](https://www.ncbi.nlm.nih.gov/pubmed/33767200/)\] \[[PMC7994717](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994717/)\]
### Database Entries (Jun 15)
Hirotsu Y, and Omata M. [‚ÄúDetection of R.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with spike protein W152L/E484K/G769V mutations in Japan.‚Äù](/search-drdb/?article=Hirotsu21) _PLOS Pathogens_, 2021. [doi.org/10.1371/journal.ppat.1009619](https://doi.org/10.1371/journal.ppat.1009619). \[[PubMed34097716](https://www.ncbi.nlm.nih.gov/pubmed/34097716/)\]
### Database Entries (Jun 12)
Varona JF, Landete P, et int., and Garc√≠a-Sastre A. [‚ÄúPlitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization.‚Äù](/search/?article=Varona21) _medRxiv_, 2021. [doi.org/10.1101/2021.05.25.21257505](https://doi.org/10.1101/2021.05.25.21257505). \[[PubMed34075384](https://www.ncbi.nlm.nih.gov/pubmed/34075384/)\] \[[PMC8168388](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168388/)\]
### Database Entries (Jun 12)
Yu J, Lu X, et int., and Li L. [‚ÄúInterferon‚ÄêŒ±‚Äê2b aerosol inhalation is associated with improved clinical outcomes in patients with coronavirus disease‚Äê2019.‚Äù](/search/?article=Yu21) _British Journal of Clinical Pharmacology_, 2021. [doi.org/10.1111/bcp.14898](https://doi.org/10.1111/bcp.14898). \[[PubMed33982806](https://www.ncbi.nlm.nih.gov/pubmed/33982806/)\]
### Database Entries (Jun 12)
Planas D, Veyer D, et int., and Schwartz O. [‚ÄúReduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals.‚Äù](/search-drdb/?article=Planas21b) _bioRxiv_, 2021. [doi.org/10.1101/2021.05.26.445838](https://doi.org/10.1101/2021.05.26.445838).
### [Clinical Trials (Jun 07)](/page/updates/#clinical.trials)
[5 clinical trials from ClinicalTrials.gov and WHO ICTRP were added to the registry of Ongoing and Planned Clinical Trials of Antiviral Compounds.](/clinical-trials/?fromDate=2021-06-07)
